11 results match your criteria: "Kenya Medical Research Institute-Centre for Geographic Medicine Research[Affiliation]"
PLoS Negl Trop Dis
October 2023
Kenya Medical Research Institute-Centre for Geographic Medicine Research, Coast, Kilifi, Kenya.
Background: Despite the importance of non-Typhoidal Salmonella (NTS) disease in Africa, epidemiologic data on carriage and transmission are few. These data are important to understand the transmission of NTS in Africa and to design control strategies.
Method: To estimate the prevalence of stool carriage of NTS in Kenya, we conducted a cross-sectional study in Kilifi, Nairobi, and Siaya, sites with a low, moderate and high incidence of invasive NTS disease, respectively.
Parasit Vectors
April 2015
Kenya Medical Research Institute - Centre for Geographic Medicine Research-Coast, P.O Box 428, 80108, Kilifi, Kenya.
Background: Members of the Anopheles gambiae complex are the main transmitters of malaria. Anopheles merus is a member of the complex found along the Kenyan coast because it breeds in saline waters. An entomological study was conducted in Garithe Malindi District, to investigate the physicochemical and environmental factors affecting the distribution of An.
View Article and Find Full Text PDFBMC Med
August 2008
Wellcome Trust/Kenya Medical Research Institute-Centre for Geographic Medicine Research Coast, Immunology Department, PO Box 230, Kilifi 80108, Kenya.
Malarial anaemia is an enormous public health problem in endemic areas and occurs predominantly in children in the first 3 years of life. Anaemia is due to both a great increase in clearance of uninfected cells and a failure of an adequate bone marrow response. Odhiambo, Stoute and colleagues show how the age distribution of malarial anaemia and the haemolysis of red blood cells may be linked by an age-dependent increase in the capacity of red blood cells to inactivate complement components absorbed or deposited directly on to the surface of the red blood cell.
View Article and Find Full Text PDFMalar J
August 2008
Kenya Medical Research Institute Centre for Geographic Medicine Research Coast, Kilifi District Hospital, Kilifi, Kenya.
Background: Antibodies targeting variant antigens expressed on the surface of Plasmodium falciparum infected erythrocytes have been associated with protection from clinical malaria. The precise target for these antibodies is unknown. The best characterized and most likely target is the erythrocyte surface-expressed variant protein family Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1).
View Article and Find Full Text PDFMalar J
November 2007
Senior Research Fellow, Kenya Medical Research Institute Centre for Geographic Medicine Research Coast (KEMRI CGMRC) Wellcome Trust Research Programme, Kilifi, Kenya, P.O. Box 230.
Background: Formal checks of participant understanding are now widely recommended to improve informed consent processes. However, the views of the participants these assessments are designed to protect are rarely considered. In this paper the findings of a qualitative study aimed at documenting community reactions to a semi-structured questionnaire ('quiz') are reported.
View Article and Find Full Text PDFMol Biochem Parasitol
July 2007
Kenya Medical Research Institute Centre for Geographic Medicine Research, Coast, Kilifi, Kenya.
J Infect Dis
November 2004
Kenya Medical Research Institute Centre for Geographic Medicine Research Coast, Kilifi, Kenya.
Erythrocytes infected with mature stages of Plasmodium falciparum express variant surface antigens (VSAs) of parasite origin, including P. falciparum erythrocyte membrane protein 1. Anti-VSA antibodies protect against clinical malaria caused by parasites bearing VSAs to which they are specific (homologous), but their role in protecting against heterologous infection is unclear.
View Article and Find Full Text PDFAims: Phenobarbital is commonly used to treat status epilepticus in resource-poor countries. Although a dose of 20 mg kg(-1) is recommended, this dose, administered intramuscularly (i.m.
View Article and Find Full Text PDFAims: Status epilepticus is common in children with severe falciparum malaria and is associated with poor outcome. Phenytoin is often used to control status epilepticus, but its water-soluble prodrug, fosphenytoin, may be more useful as it is easier to administer. We studied the pharmacokinetics and clinical effects of phenytoin and fosphenytoin sodium in children with severe falciparum malaria and status epilepticus.
View Article and Find Full Text PDFCNS Drugs
March 2003
Kenya Medical Research Institute Centre for Geographic Medicine Research, Coast, Kilifi, Kenya.
Cerebral malaria is one of the most common nontraumatic encephalopathies in the world. Children living in sub-Saharan Africa bear the brunt of the disease, but cerebral malaria is being seen increasingly in adults throughout the world, including outside malarious areas. There are differences in the clinical presentation and pathophysiology between African children and nonimmune adults from any region.
View Article and Find Full Text PDFThe kinetics of antibody responses to the Plasmodium falciparum malaria parasite-induced erythrocyte surface antigens (PIESAs) in 26 Kenyan children were examined by use of flow cytometry and agglutination assays. Although 19 of the 26 children mounted a primary antibody response to PIESAs within 2 weeks of experiencing an acute episode and maintained high antibody levels for at least 12 weeks, the remaining 7 children had responses that were weak and brief. Resistance to reparasitization was decreased in the children with short-lived responses.
View Article and Find Full Text PDF